Alexander Faussner
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Identification of a non-canonical chemokine-receptor pathway suppressing regulatory T cells to drive atherosclerosis.
Journal: Nature cardiovascular research
Published: July 24, 2024
GPR55 in B cells limits atherosclerosis development and regulates plasma cell maturation.
Journal: Nature cardiovascular research
Published: December 16, 2022
In vitro pharmacological profile of PHA-022121, a small molecule bradykinin B2 receptor antagonist in clinical development.
Journal: International immunopharmacology
Published: November 16, 2021
Chemokines and galectins form heterodimers to modulate inflammation.
Journal: EMBO reports
Published: February 01, 2019
Deficiency of Monoacylglycerol Lipase Enhances IgM Plasma Levels and Limits Atherogenesis in a CB2-Dependent Manner.
Journal: Thrombosis and haemostasis
Published: January 05, 2019
Chronic Intake of the Selective Serotonin Reuptake Inhibitor Fluoxetine Enhances Atherosclerosis.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: November 20, 2017
Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation.
Journal: Science translational medicine
Published: August 02, 2016
CD70 limits atherosclerosis and promotes macrophage function.
Journal: Thrombosis and haemostasis
Published: April 21, 2016
Cross-Linking GPVI-Fc by Anti-Fc Antibodies Potentiates Its Inhibition of Atherosclerotic Plaque- and Collagen-Induced Platelet Activation.
Journal: JACC. Basic to translational science
Published: January 26, 2016
CD27 co-stimulation increases the abundance of regulatory T cells and reduces atherosclerosis in hyperlipidaemic mice.
Journal: European heart journal
Published: November 04, 2015
Last Updated: 09/26/2026